Skip to content

    Emami

    EMAMILTD
    Fast Moving Consumer Goods·28 Jan 2025
    Management Summary

    Emami reported a resilient Q3 FY25 performance amidst a mixed macroeconomic environment, characterized by subdued urban demand and delayed winters. Despite challenges in male grooming and Kesh King, the company achieved robust growth in its core domestic business, BoroPlus, and healthcare segments. Significant margin expansion was driven by price hikes and cost reduction initiatives. Strategic rebranding of Fair and Handsome to Smart and Handsome, along with ongoing efforts in Kesh King and international markets, positions the company for future growth.

    Highlights

    8
    • Consolidated revenues for Q3 FY25 stood at INR 1,049 crores, reflecting a 5% growth.

    • Core domestic business grew by 8.6% with approximately 6% volume growth in Q3 FY25.

    • BoroPlus range demonstrated strong resilience, growing by 20% in Q3 FY25.

    • Healthcare range delivered robust growth of 13%, led by 90% growth in Zandu Care.

    • Gross margins expanded by 150 basis points to 70.3% in Q3 FY25.

    • EBITDA grew by 8% to INR 339 crores, with margins expanding by 70 basis points in Q3 FY25.

    • Profit after tax (PAT) increased by 8% to INR 279 crores in Q3 FY25.

    • The Board approved a second interim dividend of 400% (INR 4 per equity share), bringing cumulative FY24 dividends to 800% (INR 8 per share).

    Concerns

    1
    • Decline in male grooming and Kesh King segments

    What Changed1

    vs Q4 FY25

    Risks discussed6 → 7 (+1)
    Key financials

    Metrics

    11

    Periods

    2

    Headline

    6
    • Consolidated Revenue
      ₹1,049 Cr
      YoY+5%
    • Core Domestic Business Growth
      8.6%
    • Core Domestic Volume Growth
      6%
    • Gross Margin
      70.3%
    • EBITDA
      ₹339 Cr
      YoY+8%

    9M

    5
    • FY25 Core Domestic Growth
      7%
    • FY25 Core Domestic Volume Growth
      5%
    • FY25 Gross Margin
      69.6%
    • FY25 EBITDA
      ₹806 Cr
      YoY+9%
    • FY25 PAT
      ₹644 Cr
      YoY+12%

    Segment breakdown

    BoroPlus
    20% Growth
    Healthcare
    13% Growth
    Zandu Care
    90% Growth
    Navratna
    3% Growth
    Pain Management
    3% Growth
    Male Grooming (Fair & Handsome/Smart & Handsome)
    -4% Decline
    Kesh King
    -10% Decline
    Strategic Investments
    -13% Decline
    International Business
    -3% Decline
    List

    Capital allocation

    3
    medium confidence
    CategoryHeadline
    Capex

    Capex disclosed

    Dividend

    ₹4/share (interim)

    Liquidity

    Liquidity disclosed

    Operating cash flows for 9 months are estimated at INR 500-550 crores. Receivables cycle is around 16-17 days.

    Guidance & targets

    9
    CategoryTargetPriority
    Profitability
    The Man Company Q4 Performance
    Significantly better than Q3
    Medium
    Brand Performance
    Kesh King Revival
    Come with a bang
    Medium
    New Product Launches
    Smart & Handsome Male Grooming Range Rollout
    Start rolling out
    High
    Tax Rate
    Current FY Tax Rate
    8-9%
    High
    Tax Rate
    Next FY Tax Rate
    Around 10%
    High
    Pricing
    Weighted Average Price Increase
    1.5-2%
    High
    International Business
    International Business Revival
    Good revival
    Medium
    Rural Contribution
    Rural Share of Domestic Business
    53-54%
    High
    CSD Contribution
    CSD Share of Business
    Around 4%
    High

    The Man Company Q4 Performance

    next quarter
    CurrentSequential month-on-month improvement in Q3
    TargetSignificantly better than Q3

    Why it matters

    To verify the effectiveness of turnaround strategies and the brand's recovery trajectory.

    And going forward, in quarter 4, we expect quarter 4 to be significantly better than quarter 3.

    How to verify

    key_financials.segment_breakdown[name='The Man Company'].metrics[label='Growth']

    Risks & concerns

    7
    RiskSeverity

    Subdued urban demand

    Urban demand remained subdued, impacted by rising food inflation and cash-strapped retail and wholesale trade.Management acknowledged

    medium

    Delayed winters impacting seasonal categories

    Delayed winters hurt seasonal categories, further adding to the complexities of the market dynamics.Management acknowledged

    medium

    Decline in male grooming and Kesh King segments

    Male grooming declined by 4% and Kesh King by 10%, requiring strategic intervention.Management acknowledged

    high

    International business underperformance (Russia, Bangladesh)

    Massive decline in Russia due to high inflation; Bangladesh impacted by political instability and high interest rates affecting credit.Management acknowledged

    medium

    Channel conflict due to diverse SKU strategies

    Channel conflict exists, managed by segregating packs for individual channels (rural, modern trade, e-com).Management acknowledged

    medium

    Pancharishta category pressure

    The Arishtha/Asava format, including Pancharishta, is seeing volume growth pressure across the industry due to evolving consumer preferences.Management acknowledged

    medium

    Liquidity constraints in retail and wholesale trade channels

    Persistent issue since COVID, impacting credit cycles, with no clear timeline for improvement.Analyst acknowledged

    medium

    Q&A highlights

    8

    “So, Avnish, yes, BoroPlus growth has been led by the core antiseptic cream, okay, where we have grown phenomenally in double digits, more than 20%. So yes, I would say the base was also low, but even though even at a lower base, growth of 20% was really exciting.”

    Clarifies that strong growth in key segments like BoroPlus and Healthcare was driven by core products and market share gains, not just base effect, indicating underlying strength.

    asked by Avnish Roy

    3 min read7 chapters

    Detailed Narrative

    01

    Q3 FY25 Performance Overview and Macroeconomic Context

    Emami reported consolidated revenues of INR 1,049 crores for Q3 FY25, marking a 5% growth. The core domestic business grew by a robust 8.6%, with approximately 6% volume growth. This performance was achieved despite a mixed macroeconomic environment, including subdued urban demand, rising food inflation, and delayed winters impacting seasonal categories. Rural demand, however, showed resilience, supported by favorable monsoons and good harvests.

    02

    Segmental Performance Highlights and Challenges

    The BoroPlus range demonstrated remarkable resilience, growing by 20%, primarily driven by antiseptic cream. The healthcare range delivered strong growth of 13%, with Zandu Care leading at 90% growth, while Navratna and Pain Management grew by 3% each. Conversely, male grooming (Fair & Handsome/Smart & Handsome) and Kesh King declined by 4% and 10% respectively. Strategic investments and international business also saw declines of 13% and 3% respectively.

    03

    Margin Expansion and Profitability

    The company achieved significant margin expansion in Q3 FY25. Gross margins expanded by 150 basis points to 70.3%, driven by price hikes, improved realizations, lower input prices (especially packaging materials), and cost reduction initiatives. EBITDA grew by 8% to INR 339 crores, with margins expanding by 70 basis points. Profit after tax (PAT) also increased by 8% to INR 279 crores, reflecting efficient cost management and improved operational leverage.

    04

    Strategic Brand Initiatives: Smart & Handsome and Kesh King

    A significant milestone was the rebranding of Fair and Handsome to Smart and Handsome, aiming to cater to a wider male grooming portfolio. The transition for base cream and face wash is complete, with new advertising launched in January 2025, and extensions rolling out in the next 3-4 months. For Kesh King, which declined by 10%, a strategic evaluation by BCG is underway, with management expecting a revival within the next one or two quarters. The Man Company is also showing sequential month-on-month improvement, with Q4 expected to be significantly better than Q3.

    05

    Distribution and Channel Dynamics

    Organized channels, including modern trade, e-commerce, and institutional sales, now contribute 28.6% of domestic business, an increase of 160 basis points. These channels grew at nearly double the pace of overall domestic business. The company manages channel conflict by segregating product packs for different channels (sachets for rural, large packs for modern trade/e-commerce, mid-packs for general trade). Rural contribution to domestic business is estimated at 53-54%, with CSD contributing around 4%.

    06

    International Business Challenges and Outlook

    The international business faced challenges, declining by 3% in Q3. A major factor was a 'massive decline' in Russia due to high inflation, although 9-month cumulative growth for Russia remains double-digit. Bangladesh also experienced mixed responses to new launches and political instability. The company is expanding product offerings in Africa and GCC MENA regions and anticipates a 'good revival' in the international business in Q4.

    07

    Capital Allocation and Shareholder Returns

    The Board approved a second interim dividend of 400%, translating to INR 4 per equity share for FY24. This brings the cumulative dividends for FY24 to 800%, or INR 8 per share, reinforcing the commitment to shareholder returns. The company reported minimal capital expenditure up to December 2024, with estimated operating cash flows for the nine months at INR 500-550 crores. Receivables cycle is stable at 16-17 days.

    This is an AI-generated summary of a publicly available earnings call transcript. It is for informational purposes only and does not constitute investment advice, a recommendation, or an endorsement. inve.money is not a SEBI-registered investment advisor. Please consult a qualified financial advisor before making any investment decisions.